These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7518975

  • 1. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P.
    Transplantation; 1994 Jul 27; 58(2):170-8. PubMed ID: 7518975
    [Abstract] [Full Text] [Related]

  • 2. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P.
    Transplantation; 1994 Jul 27; 58(2):155-70. PubMed ID: 7518974
    [Abstract] [Full Text] [Related]

  • 3. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients.
    Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P.
    Transpl Int; 1994 Jul 27; 7 Suppl 1():S52-7. PubMed ID: 11271297
    [Abstract] [Full Text] [Related]

  • 4. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.
    Clin Transplant; 1995 Jun 27; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [Abstract] [Full Text] [Related]

  • 5. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 27; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX, Shan HT, Fu SJ, Du CF, Ma JJ, Xu J, Deng WF, Wang YB.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov 27; 23(11):1146-8. PubMed ID: 14625173
    [Abstract] [Full Text] [Related]

  • 7. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM.
    Transplantation; 1995 Feb 27; 59(4):530-6. PubMed ID: 7533345
    [Abstract] [Full Text] [Related]

  • 8. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
    Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Jun 27; 9(3 Pt 1):176-84. PubMed ID: 7549057
    [Abstract] [Full Text] [Related]

  • 9. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 27; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 11. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun 27; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 12. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 13. Acute renal failure after cadaveric related liver transplantation.
    Chuang FR, Lin CC, Wang PH, Cheng YF, Hsu KT, Chen YS, Lee CH, Chen CL.
    Transplant Proc; 2004 Oct 27; 36(8):2328-30. PubMed ID: 15561239
    [Abstract] [Full Text] [Related]

  • 14. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M.
    Transplantation; 1995 Jan 15; 59(1):31-40. PubMed ID: 7530868
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T, CRAF Study Group.
    Clin Transplant; 2005 Oct 15; 19(5):573-80. PubMed ID: 16146546
    [Abstract] [Full Text] [Related]

  • 16. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK, Xie XB, Peng FH, Wang Y, Jiang Y, Lan GB, Fang CH, Nie MH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb 15; 32(1):59-62. PubMed ID: 17344588
    [Abstract] [Full Text] [Related]

  • 17. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ.
    J Heart Lung Transplant; 1996 Apr 15; 15(4):415-22. PubMed ID: 8732602
    [Abstract] [Full Text] [Related]

  • 18. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
    Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM.
    Transplantation; 1995 Mar 27; 59(6):851-9. PubMed ID: 7535482
    [Abstract] [Full Text] [Related]

  • 19. [Application of tacrolimus and cyclosporine A in HBV-carrying renal transplant recipients].
    Liu XY, Yu LX, Fu SJ, Xu J, Du CF, Deng WF, Wang YB, Ye GR, Zhang YX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul 27; 27(7):1090-2. PubMed ID: 17666359
    [Abstract] [Full Text] [Related]

  • 20. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec 27; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.